Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolle Sweeney

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Opinion in Immunology|November 11, 2025
Can we cure autoimmunity?Nicolle Sweeney, Yemil Atisha-Fregoso, Rita Pozovskiy, et al.
Mabs|June 4, 2025
Higher order receptor clustering due to the IgG3 subclass is necessary for TLR4 signaling and tolerance induction by novel human anti-TLR4 antibodiesLuke S Heuer, Nicolle Sweeney, Manuel Rojas, et al.
Frontiers in Immunology|November 30, 2023
Activation of the aryl hydrocarbon receptor inhibits neuropilin-1 upregulation on IL-2-responding CD4<sup>+</sup> T cellsSimone Sandoval, Keegan Malany, Krista Thongphanh, et al.
Journal of Autoimmunity|November 8, 2025
Alternate splicing converts human CD137 from costimulatory to immunosuppressive functionManuel Rojas, Luke S Heuer, Weici Zhang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Opinion in Immunology|November 11, 2025
Can we cure autoimmunity?Nicolle Sweeney, Yemil Atisha-Fregoso, Rita Pozovskiy, et al.
Mabs|June 4, 2025
Higher order receptor clustering due to the IgG3 subclass is necessary for TLR4 signaling and tolerance induction by novel human anti-TLR4 antibodiesLuke S Heuer, Nicolle Sweeney, Manuel Rojas, et al.
Frontiers in Immunology|November 30, 2023
Activation of the aryl hydrocarbon receptor inhibits neuropilin-1 upregulation on IL-2-responding CD4<sup>+</sup> T cellsSimone Sandoval, Keegan Malany, Krista Thongphanh, et al.
Journal of Autoimmunity|November 8, 2025
Alternate splicing converts human CD137 from costimulatory to immunosuppressive functionManuel Rojas, Luke S Heuer, Weici Zhang, et al.
Pageof 1